Former drug company CEO Martin Shrkeli has been hit with a new conspiracy charge, according to reports Saturday.
Federal prosecutors in Brooklyn, N.Y., filed a new indictment against Shrkeli and his former attorney Evan Greebel for attempting to defraud potential investors of his former drug company, Retrophin Inc.
Shkreli last month announced his support for Donald Trump over Hillary Clinton, tweeting that people who do not like Trump “are jealous, stupid and poor! don’t make me laugh! and if you are employed by media you are worthless.”
Both Shkreli and Greebel were arrested last December after being accused of taking stock from one company to pay debts related to other business dealings.
Shkreli pleaded “not guilty” to charges of securities fraud and conspiracy while Greebel has pleaded “not guilty” to a single count of wire-fraud conspiracy. Shkreli was released on a $5 million bond. If convicted, he faces up to 20 years in prison.
The former pharmaceuticals executive will appear in federal court Monday where he may be arraigned for the new charge.
In a statement, Shkreli’s attorney said, “There is nothing in the new indictment that impacts in any way on the flawed theory of the case as applied to Mr. Shkreli.”
Shkreli, founder and former CEO of Turing Pharmaceuticals, received near-universal criticism for raising the price of the anti-parasite drug Daraprim by over 5,000 percent in late 2015.
